The Quiet Battle Over Compounding — and Why Colorado’s SB 26-066 Matters Now

Untitled design 2026 03 23T144519.777

From renewed FDA scrutiny to sharp criticism from segments of organized medicine, and even debates spilling into mainstream media, compounded medications have become the focus of a growing national conversation.  At first glance, the issue is framed as one of safety.  But as with many things in medicine, the reality is more nuanced.  And now, […]